Connection

CHAAN S NG to Contrast Media

This is a "connection" page, showing publications CHAAN S NG has written about Contrast Media.
Connection Strength

2.543
  1. Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis. Cancer Imaging. 2018 Aug 24; 18(1):30.
    View in: PubMed
    Score: 0.405
  2. Observer Variability in CT Perfusion Parameters in Primary and Metastatic Tumors in the Lung. Technol Cancer Res Treat. 2018 01 01; 17:1533034618769767.
    View in: PubMed
    Score: 0.387
  3. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model. Technol Cancer Res Treat. 2012 Jun; 11(3):279-88.
    View in: PubMed
    Score: 0.259
  4. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol. 2010 Feb; 194(2):W134-40.
    View in: PubMed
    Score: 0.224
  5. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115.
    View in: PubMed
    Score: 0.100
  6. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol. 2018 Apr; 210(4):W156-W163.
    View in: PubMed
    Score: 0.098
  7. Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance. Acad Radiol. 2018 07; 25(7):861-868.
    View in: PubMed
    Score: 0.097
  8. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017 Jun; 43(6):785-794.
    View in: PubMed
    Score: 0.091
  9. CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study. Clin Cancer Res. 2017 Jul 15; 23(14):3684-3691.
    View in: PubMed
    Score: 0.091
  10. Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors. Comput Med Imaging Graph. 2016 Mar; 48:1-8.
    View in: PubMed
    Score: 0.084
  11. CT Perfusion Characteristics Identify Metastatic Sites in Liver. Biomed Res Int. 2015; 2015:120749.
    View in: PubMed
    Score: 0.083
  12. Dependence of DCE-MRI biomarker values on analysis algorithm. PLoS One. 2015; 10(7):e0130168.
    View in: PubMed
    Score: 0.082
  13. Computed tomography and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings in adrenal candidiasis and histoplasmosis: two cases. Clin Imaging. 2015 Nov-Dec; 39(6):1115-8.
    View in: PubMed
    Score: 0.082
  14. Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver. J Comput Assist Tomogr. 2012 Jul-Aug; 36(4):388-93.
    View in: PubMed
    Score: 0.066
  15. Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy. AJR Am J Roentgenol. 2011 Mar; 196(3):569-76.
    View in: PubMed
    Score: 0.060
  16. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging. 2011 Jul-Aug; 6(4):289-97.
    View in: PubMed
    Score: 0.060
  17. Targeted imaging of tumor-associated M2 macrophages using a macromolecular contrast agent PG-Gd-NIR813. Biomaterials. 2010 Sep; 31(25):6567-73.
    View in: PubMed
    Score: 0.058
  18. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol. 2010 Aug; 195(2):414-22.
    View in: PubMed
    Score: 0.058
  19. 4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning. Radiother Oncol. 2008 Jun; 87(3):445-8.
    View in: PubMed
    Score: 0.049
  20. Comparison of enhancement quantification from virtual unenhanced images to true unenhanced images in multiphase renal Dual-Energy computed tomography: A phantom study. J Appl Clin Med Phys. 2019 Aug; 20(8):171-179.
    View in: PubMed
    Score: 0.027
  21. PET/CT in the management of patients with stage IIIC and IV metastatic melanoma considered candidates for surgery: evaluation of the additive value after conventional imaging. AJR Am J Roentgenol. 2012 Apr; 198(4):902-8.
    View in: PubMed
    Score: 0.016
  22. Daily targeting of liver tumors: screening patients with a mock treatment and using a combination of internal and external fiducials for image-guided respiratory-gated radiotherapy. Med Phys. 2007 Dec; 34(12):4591-3.
    View in: PubMed
    Score: 0.012
  23. CT quantification of effects of thalidomide in patients with metastatic renal cell carcinoma. AJR Am J Roentgenol. 2007 Aug; 189(2):378-85.
    View in: PubMed
    Score: 0.012
  24. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):830-8.
    View in: PubMed
    Score: 0.011
  25. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol. 2005 Aug 20; 23(24):5464-73.
    View in: PubMed
    Score: 0.010
  26. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005 Jul-Aug; 29(4):263-5.
    View in: PubMed
    Score: 0.010
  27. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr. 2004 Nov-Dec; 28(6):804-10.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.